Alphapharm Pty Limited Pharmaceutical Import Profile — Australia (DGFT 2022–2026)

Name: Alphapharm Pty Limited Pharmaceutical Import Records from India — 2 Products, $733.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Alphapharm Pty Limited — Pharmaceutical Importer Profile (2026) | 2 Products, $733.1K Trade | TransData Nexus

Alphapharm Pty Limited

Pharmaceutical Importer · Australia · Antibiotics Focus · $733.1K Total Trade · DGFT Verified

Alphapharm Pty Limited is a pharmaceutical importer based in Australia with a total trade value of $733.1K across 2 products in 2 therapeutic categories. Based on 16 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Alphapharm Pty Limited sources from 12 verified Indian suppliers, with Mylan Laboratories Limited accounting for 35.2% of imports.

Alphapharm Pty Limited — Import Portfolio & Supplier Network

Alphapharm Pty Limited import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Alphapharm Pty Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mylan Laboratories Limited	$3.3M	149	35.2%
Intas Pharmaceuticals Limited	$2.9M	179	31.1%
Alembic Pharmaceuticals Limited

What Formulations Does Alphapharm Pty Limited Import?

Formulation	Value	Ships
Adesan 32 MG TAB 30bl 3x10's	$196.9K	6
Phrm drug&med:lyzalon pregabalin 75MG	$181.9K	5
Cadivast 10/80 TAB 30bt 30's	$150.0K	3
Cilatil 5 MG 28bl TAB (2x14's blister	$150.0K	3
Mizart hct 80/12.5MG 4x7t	$137.6K	4
Harmless medicines: noxicid CAPS 20MG 30bt (Pack:108377.000	$136.5K	3
Pharm drug&med:lyzalon pregabalin 25MG 4x14caus Each hard gelatin capsule contains:pregabalin 25MG excipient	$124.7K	4
Phrm drug&med:lyzalon pregabalin 150MG	$112.0K	3
Mizart (telmi) 80MG 4x7t	$110.8K	3
Pharm drug&med:olsetan olmesartan 40MG 3x10t(via-aus)Each film coat tabl cont:olmesartan medoxomil PH.EUR 40MG(asperinv)	$105.8K	3
Ampicillin (as sodium) powder for	$100.0K	2
Noxicid CAPS 20MG 30bt 127192 packs x	$100.0K	2
Diaformin 1000MG 6x15s-viatris/at-pc476	$100.0K	2
Mizart (telmi) 80MG 4x7	$100.0K	2
Clonea antifungal cream 1%	$98.2K	4

Alphapharm Pty Limited imports 299 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Tobramycin	Antibiotics	$600.0K	12	1.5%	15
2	Fluorouracil	Oncology	$133.1K	4	1.1%	18

Alphapharm Pty Limited imports 2 pharmaceutical products across 2 categories into Australia totaling $733.1K.

Alphapharm Pty Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Alphapharm Pty Limited, established in 1982, is a prominent Australian pharmaceutical company specializing in the manufacturing and distribution of generic medicines. Headquartered in Sydney, New South Wales, Alphapharm operates as a subsidiary of Mylan Inc., a global leader in generic and specialty pharmaceuticals. The company has a workforce of approximately 500 to 1,000 employees and exports its products to over 50 countries, including Europe and the United States.

In Australia, Alphapharm holds a significant position in the pharmaceutical supply chain, being the largest sole supplier to the Pharmaceutical Benefits Scheme (PBS) by the number of PBS-subsidized prescriptions. This underscores its pivotal role in providing affordable and accessible medications to the Australian public.

2Distribution Network

Alphapharm's distribution network is strategically designed to ensure nationwide coverage across Australia. While specific warehouse locations are not publicly disclosed, the company's extensive logistics capabilities facilitate the efficient delivery of pharmaceutical products to various regions. This infrastructure supports its role as a primary wholesaler and supplier to the PBS, ensuring timely and reliable access to essential medications for healthcare providers and patients.

3Industry Role

Alphapharm Pty Limited functions primarily as a wholesaler and distributor within Australia's pharmaceutical supply chain. Its substantial involvement in the PBS highlights its critical role in supplying subsidized medications to the Australian healthcare system. Additionally, Alphapharm's export activities to over 50 countries, including Europe and the United States, position it as a significant player in the global generic pharmaceutical market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Alphapharm Pty Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Alphapharm's sourcing strategy exhibits a high degree of concentration, with a portfolio comprising only two imported products: Tobramycin and Fluorouracil. This focus indicates a strategic choice to specialize in these therapeutic areas, potentially leveraging expertise and market demand. The substantial import value of Tobramycin ($600K) and Fluorouracil ($133K) suggests a stable and ongoing relationship with Indian suppliers. However, the lack of diversification in imported products may expose Alphapharm to supply chain risks, such as dependency on specific suppliers or geopolitical factors affecting trade routes.

2Supply Chain Resilience

Alphapharm's supply chain resilience is influenced by its concentrated sourcing from Indian suppliers. The company's import data indicates a reliance on a limited number of suppliers for its two imported products. This concentration could pose risks if any of these suppliers face operational disruptions or regulatory challenges. To mitigate such risks, Alphapharm may consider diversifying its supplier base and exploring alternative sourcing options to enhance supply chain robustness.

3Strategic Implications

Importing Pharmaceuticals into Australia — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Australia

1Regulatory Authority & Framework

In Australia, the Therapeutic Goods Administration (TGA) is the primary regulatory body overseeing the importation, manufacturing, and distribution of pharmaceutical products. The TGA ensures that medicines meet strict safety, efficacy, and quality standards before they are made available to the public. Key legislation governing pharmaceutical imports includes the Therapeutic Goods Act 1989, which outlines the requirements for marketing authorization, and the Therapeutic Goods Administration Act 1989, which establishes the TGA's authority and responsibilities.

2Import Licensing & GMP

Import licensing in Australia requires that pharmaceutical products be registered with the TGA, demonstrating compliance with Good Manufacturing Practice (GMP) standards. The TGA recognizes GMP certifications from reputable international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Indian exporters seeking to supply Alphapharm must ensure that their manufacturing facilities hold valid GMP certifications from these recognized authorities to meet Australian import requirements.

3Quality & Labeling

Alphapharm Pty Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Alphapharm's focus on importing antibiotics and oncology medications aligns with the significant demand for these therapeutic areas in Australia. Antibiotics are essential for treating a wide range of infections, while oncology drugs are critical for cancer treatment. The substantial import value of Tobramycin and Fluorouracil indicates a strategic emphasis on these high-demand products, catering to the needs of healthcare providers and patients.

2Sourcing Profile

Alphapharm's sourcing strategy for generic drugs involves importing finished pharmaceutical formulations from India, a country known for its robust pharmaceutical manufacturing capabilities. The company's focus on specific formulations, such as Tobramycin and Fluorouracil, suggests a targeted approach to procurement, ensuring access to high-quality products that meet Australian standards.

3Market Positioning

Alphapharm serves the Australian market by supplying generic medications to various segments, including retail pharmacies, hospitals, and government tenders. Its significant role in the PBS underscores its position in providing affordable medications to the general public. The company's export activities further position it as a key player in the global pharmaceutical market.

Seller's Guide — How to Become a Supplier to Alphapharm Pty Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Alphapharm, particularly in the antibiotics and oncology therapeutic areas. Alphapharm's concentrated sourcing strategy indicates a potential openness to establishing strong supplier relationships. Prospective suppliers should focus on meeting Alphapharm's stringent quality standards, obtaining necessary GMP certifications, and understanding the regulatory requirements of the Australian market to effectively enter this partnership.

2Requirements & Qualifications

Indian exporters aiming to supply Alphapharm must ensure that their manufacturing facilities hold valid GMP certifications recognized by the TGA, such as EU GMP, WHO GMP, or PIC/S. Additionally, products must comply with TGA regulations concerning batch testing, stability, labeling, and serialization. Understanding and adhering to these requirements is crucial for successful market entry.

3How to Approach

Frequently Asked Questions — Alphapharm Pty Limited

What products does Alphapharm Pty Limited import from India?

Alphapharm Pty Limited imports 2 pharmaceutical products across 2 categories. Top imports: Tobramycin ($600.0K), Fluorouracil ($133.1K).

Who supplies pharmaceuticals to Alphapharm Pty Limited from India?

Alphapharm Pty Limited sources from 12 verified Indian suppliers. The primary supplier is Mylan Laboratories Limited (35.2% of imports, $3.3M).

What is Alphapharm Pty Limited's total pharmaceutical import value?

Alphapharm Pty Limited's total pharmaceutical import value from India is $733.1K, based on 16 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Alphapharm Pty Limited focus on?

Alphapharm Pty Limited imports across 2 categories. The largest: Antibiotics (81.8%), Oncology (18.2%).

Get Full Alphapharm Pty Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.